B i c o m pa r t m e n ta l K n e e A r t h r o p l a s t y

Surgical Technique Overview

 Femoral array 1. Perform a medial incision and
parapatellar arthrotomy to expose the
Medial parapatellar incision joint. Place the femoral and tibial arrays,
and the femoral and tibial checkpoints.
Tibial array

2. Measure the thickness of the patella and

resect it in the customary fashion.

3. Collect patient landmarks. Register and

verify the femoral and tibial checkpoints.
Perform bone registration and verification
of both the femoral and tibial surfaces.

Femoral checkpoint  o not remove osteophytes before

D
Tibial checkpoint bone registration is completed.
Exposed medial
compartment
Valgus stress applied
4. Remove overhanging medial osteophytes and
then capture a minimum of 4 poses while
applying a valgus stress to passively correct
the coronal deformity. The magnitude of
Medial collateral the valgus stress must be such that it opens
ligament (MCL) up the collapsed medial compartment and
tensions the medial collateral ligament (MCL)
to achieve the desired degree of correction
and joint stability.
C
 aution must be exercised to not
overcorrect the deformity.

0˚ 
The poses captured are in extension,
10˚ mid-flexion, flexion, and full-flexion (or
approximately 10,̊ 45,̊ 90,̊ and 120˚).
45˚

120˚ 90˚

5. Map cartilage along the trochlear groove

and in the distal femoral transition zones.
Fine-tune the femoral and tibial implant
placement to ensure:
- Joint gaps are 0-1.5mm of looseness
throughout range of motion

- Good central loading between the femoral

and tibial components

F ine-tune the PF component position

to ensure smooth transition from the
implant to the femoral condyles and
femoral component.

6. Position the RIO ® in the operative field

and perform registration and verification
of the robotic arm.
 7. Resect the femoral, tibial, and trochlear
surfaces and create their respective
peg holes.

8. Remove any meniscus and other soft

tissues. Clean up the joint and install
trial components. Take the limb through
range of motion to assess joint stability.

9. Wash the joint with pulse lavage and

dry before cementing the final implants.
Final implants Ensure that there is good pressurization
of the cement to achieve good inter-
digitation. Remove all extraneous cement
and then keep the joint stable until
cement cures.
Once cement cures, reassess joint stability,
tibiofemoral central tracking, and range
of motion.
Remove checkpoints, bone pins,
and arrays. Close the surgical wound
in the normal fashion.
P
 ulse lavage on pin sites may help
reduce risk of pain and infection.

For detailed instructions, please refer to RESTORIS® MCK Planning and Surgical Technique Guide #206591.
MAKOplasty — It’s PKA Redefined ®

MAKOplasty Makes the Complex Consistent for

Enhanced Surgical Results

• Increased accuracy and lower post-operative pain levels from Day 1

up to 8 weeks vs. manual unicompartmental knee arthroplasty (UKA)
using Oxford® implants1
• Increased range of motion, quadriceps strength, and post-operative
functionality vs. manual total knee arthroplasty (TKA) and navigated
manual TKA2
• Very low revision rate of 1.1% at two years demonstrated in a
multicenter trial of 752 patients (854 knees)3
Oxford is a registered trademark of Biomet, Inc.
 MAKOplasty PKA ®

Comprehensive Solutions

Medial Patellofemoral Lateral Bicompartmental

Indications
RESTORIS® Partial Knee Application:
The RESTORIS® Partial Knee Application, for use with the Robotic Arm Interactive Orthopedic System (RIO), is intended to assist the
surgeon in providing software-defined spatial boundaries for orientation and reference information to anatomical structures during
orthopedic procedures.

The RESTORIS Partial Knee Application, for use with the Robotic Arm Interactive Orthopedic System (RIO), is indicated for use in
surgical knee procedures, in which the use of stereotactic surgery may be appropriate, and where reference to rigid anatomical bony
structures can be identified relative to a CT-based model of the anatomy. These procedures include unicondylar knee replacement
and/or patellofemoral knee replacement. A surgeon must always rely on his or her own
professional clinical judgment when deciding
RESTORIS® MCK Implant System: whether to use a particular product when treating
RESTORIS MCK Bicompartmental is indicated for single or multicompartmental knee replacement used in conjunction with RIO, the a particular patient. Stryker does not dispense
Robotic Arm Interactive Orthopedic System, in individuals with osteoarthritis or post-traumatic arthritis of the tibiofemoral and/or medical advice and recommends that surgeons
patellofemoral articular surfaces. The specific knee replacement configurations include:
be trained in the use of any particular product
1. Medial unicondylar
before using it in surgery.
2. Lateral unicondylar
3. Patellofemoral The information presented is intended to
4. Medial bicompartmental (medial unicondylar and patellofemoral) demonstrate the breadth of Stryker product
RESTORIS MCK is for single use only and is intended for implantation with bone cement. offerings. A surgeon must always refer to the
package insert, product label and/or instructions
for use before using any Stryker product.
Products may not be available in all markets
References because product availability is subject to the
1. Blyth
 MJ, Smith J, Jones B, MacLean AD III, Anthony I, Rowe P. Does robotic surgical assistance improve the accuracy of implant placement regulatory and/or medical practices in individual
in unicompartmental knee arthroplasty? AAOS 2013 Annual Meeting, March 19–23, Chicago, IL.
markets. Please contact your Stryker
2. Kreuzer
 S, Conditt M, Jones J, Dalal S, Pourmoghaddam A. Functional recovery after bicompartmental arthroplasty, navigated TKA,
and traditional TKA. 25th Annual Congress of ISTA, October 3–6, 2012, Sydney, Australia.
representative if you have questions about the
availability of Stryker products in your area.
3. Coon
 T, Roche M, Pearle A, Dounchis J, Borus T, Buechel Jr F. Two year survivorship of robotically guided unicompartmental knee
arthroplasty. ISTA 26th Annual Congress, October 16–19, 2013, Palm Beach, FL.
Stryker Corporation or its divisions or other
Stryker Australia Pty Ltd Stryker New Zealand Limited corporate affiliated entities own, use or have
8 Herbert Street St Leonards 515 Mt. Wellington Highway applied for the following trademarks or service
NSW 2065 Australia Auckland 1060 New Zealand marks: Stryker/Mako. All other trademarks are
Ph: +61 2 9467 1000 Ph: +64 9 573 1890 trademarks of their respective owners or holders.
www.stryker.com.au www.stryker.com
All claims of product performance and indications for use contained within this document relate only to data submitted
to and reviewed by regulatory authorities in those jurisdictions in which clearance(s) and/or approval(s) have been
obtained, including the United States. No product performance claims or indications for use are made for jurisdictions
in which such clearance(s) and/or approval(s) have not been obtained.

Visit our consumer website at makoplasty.com

2555 Davie Road | Fort Lauderdale, FL 33317 | 866.647.6256 | makosurgical.com
© 2013 MAKO Surgical Corp. 209346 r00 / ECN 5375 10/13